Author:
Chen Ying Jie,Traverse Jay H.,Bache Robert J.
Reference40 articles.
1. Murad F, Waldman S, Molina C, et al. Regulation and role of guanylate cyclasecyclic GMP in vascular relaxation. Prog Clin Biol 1987; 249: 65–76.
2. Polson JB, Strada SJ. Cyclic nucleotide phosphodiesterases and vascular smooth muscle. Annu Rev Pharmacol Toxicol 1996; 36: 403–427.
3. Ahn HS, Crim W, Pitts B, et al. Calcium-calmodulin-stimulated and cyclic-GMPspecific phosphodiesterases. Tissue distribution, drug sensitivity, and regulation of cyclic GMP levels. Adv Sec Messenger Phosphoprotein Res 1992; 25: 271–288.
4. Hagiwara M, Endo T, Hidaka H. Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle. Biochem Pharmacol 1984; 33: 453–457.
5. Merkel LA, Rivera LM, Perrone MH, et al. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor. Eur J Pharmacol 1992; 216: 29–35.